Orthobiologics Market 2018-2023 : Global Top Key Players (ALLERGAN PLC., APOTEX INC., ASTELLAS PHARMA INC., AUROBINDO PHARMA LIMITED, COGENTIX MEDICAL INC., ENDO INTERNATIONAL PLC, HISAMITSU PHARMACEUTICAL CO. INC., INTAS PHARMACEUTICALS LTD, JOHNSON & JO

Global Orthobiologics Market : Demand, Trend, Latest Innovations & Technology, Applications Analysis and 2018-2023 Industry Growth Forecast Research Report- Orbis Research.

The global orthobiologics market is projected to register a CAGR of about 5.4% during the forecast period, 2018-2023. Orthobiologics are used by orthopedic surgeons to help injuries heal more quickly. They are used to quicken the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in our body.

Increasing Patient Preference for Minimally Invasive Procedures

Orthobiologic therapy is a minimally invasive therapy and one of the components of regenerative medicine that are used to treat several musculoskeletal ailments, including degenerative osteoarthritis. Lately, orthobiologics have come to be known as one of the prominent treatment option for early osteoarthritis (OA) of the knee.

Download a PDF Sample of this Report @ http://orbisresearch.com/contacts/request-sample/2213804#utm_source=shreyas

The interests about orthobiologcs in the medical community and growing research in the field of regenerative medicine, coupled with promising clinical results from the use of orthobiologics are helping to make the clinical applications of this treatment more diverse every day.

Biological therapy or cellular arthroplasty is evolving rapidly in the management of OA. Repair of damaged cartilage and biological restitution can be possible by the judicious use of autologous biological products. This will help the orthobiologics market to flourish during the forecast period.

High Cost Associated with Orthobiologics-Based Treatments

Treatments involving orthobiologics are expensive and often not covered by the governments. This is owing to the fact that this form of treatment is relatively new and there have not been enough studies to prove their efficacy and effectiveness in treating the patients. Also, the possibility of alternative form of treatments mean that patients who are skeptical about this form of treatment can opt for other alternative treatments available. This will lead to the slowdown of the growth of this market.

North America to Maintain Lead in the Market

North America is expected to command the largest share of the market in 2017 due to the increasing incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and growing physician and patient awareness about newly introduced treatment procedures and technologies. However, Asia Pacific is expected to register the highest growth rate during the forecast period.

The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.

Access the complete report with TOC & List of Tables @ http://orbisresearch.com/contacts/request-sample/2213804

Key Developments:

February 2018 - A conference was comducted that focused on orthobiologics at the Orthobiologic Singularity event, orthopedic medicine from invasive to regenerative.
Sep 2017 - Bioventus, a global leader in orthobiologic solutions, announced that the US FDA approval was granted for DUROLANE, a single-injection, hyaluronic acid.

Major Players: ALLERGAN PLC., APOTEX INC., ASTELLAS PHARMA INC., AUROBINDO PHARMA LIMITED, COGENTIX MEDICAL INC., ENDO INTERNATIONAL PLC, HISAMITSU PHARMACEUTICAL CO. INC., INTAS PHARMACEUTICALS LTD, JOHNSON & JOHNSON, MACLEODS PHARMACEUTICALS LTD, MEDTRONIC PLC, MYLAN NV, PFIZER INC., SANOFI, AND TEVA PHARMACEUTICAL INDUSTRIES LIMITED, amongst others.

Reasons to Purchase the Report

Current and future orthobiologics market outlook in the developed and emerging markets
Analysis of various perspectives of the market with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3 months analyst support, along with the Market Estimate sheet (in Excel)

Enquiry before buying report @ http://orbisresearch.com/contacts/enquiry-before-buying/2213804#utm_source=shreyas

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

Table of Content

Introduction
1.1 Market Definition

Research Methodology
Executive Summary
Key Inferences
Market Overview
5.1 Current Market Scenario

5.2 Porter's Five Forces Analysis

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Consumers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitute Product and Services

5.2.5 Competitive Rivalry Within the Industry

Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers

6.1.1 Increasing Incidence of Sports Injuries and Road Accidents

6.1.2 Increasing Incidence of Osteoarthritis

6.1.3 Rising Geriatric and Obese Population

6.1.4 Increasing Patient Preference for Minimally Invasive Procedures

6.2 Market Restraint

6.2.1 High Costs Associated With Orthobiologics-based Treatments

6.2.2 Preference for Alternative Treatment Options

6.3 Opportunities

6.4 Key Challenges

Market Segmentation
Competitive Landscape
8.1 Mergers & Acquisition Analysis

8.2 Agreements, Collaborations, and Partnerships

8.3 New Products Launches

Key Players
9.1 Arthrex Inc.

9.2 Bioventus LLC

9.3 Depuy Synthes (A Subsidiary of Johnson & Johnson)

9.4 Globus Medical Inc.

9.5 Harvest Technologies Corporation (A Terumo Bct Company)

9.6 K2M Group Holdings Inc.

9.7 Kuros Biosciences Ltd

9.8 Medtronic PLC

9.9 Nuvasive Inc.

9.10 Orthofix International NV

9.11 RTI Surgical Inc.

9.12 Seaspine Holdings Corporation

9.13 Stryker Corporation

9.14 Xtant Medical Holdings Inc.

9.15 Zimmer Biomet Holdings Inc.

*List not Exhaustive

Future of the Market

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.